cardinal glennon children’s medical center -...

Henry B. Randall, MD FACS

Curriculum Vitae

Current Position:

May 2015 Division Chief, Adult & Pediatric Transplantation

Associate Professor of Surgery,

Saint Louis University

Cardinal Glennon Children’s Medical Center

Surgical Director of Liver Transplantation,

Center for Abdominal Transplantation

February 2015 Associate Professor of Surgery

Saint Louis University

Surgical Director of Liver Transplantation

Center for Abdominal Transplantation

August 2014 Physician Executive

Informatics & Health Information Technology

The Cerner, Corp.

April 2014 CEO & Co-Founder, The Randall Group, LLC

Healthcare Consulting Firm

Mobile Applications & Web Development

April 2014 Manager, The Black Diamonds Group, LLC

Technology Transfer Specialists

Office

3635 Vista Ave.

FDT 11th

Floor

Saint Louis, MO 63110

Education

June 1977 – May 1978 Western Michigan University Kalamazoo, MI

June 1979 - March 1984 Bachelor of Science, College of Natural Sciences

Michigan State University East Lansing, MI

June 1984 - July1986 Graduate Studies: Molecular Biology & Biophysics

Wayne State University Detroit, MI

June 1986 - June 1990 Doctor of Medicine

Wayne State University School of Medicine

Detroit, MI

Post graduate training

July 1990 - June 1998 University of California San Francisco-East Bay,

General Surgery

(Formerly UC Davis-East Bay)

June 1993-July 1996 University of California at San Francisco

NIH-UCSF Gastrointestinal Training Grant

Research Fellow in Transplant Immunology

Sponsor: Dean, School of Medicine

Haile Debas, MD

Advisors: John P. Roberts, MD; Professor of Surgery

Chief of Transplant Services, UCSF

Nancy L. Ascher, MD, PhD;

Professor, Chair of Surgery, UCSF

June 1998-July 2000 University of California at San Francisco

Clinical Abdominal Transplantation Fellowship

Area of Focus: Liver, Kidney, & Pancreas Transplantation

Adult and Pediatric Liver and Kidney

Transplantation

Split Liver & Live Donor Liver & Kidney

Transplantation

Hepatobiliary Surgery

Advisors: John P. Roberts, MD; Professor of Surgery

Chief of Transplant Services, UCSF

Nancy L. Ascher, MD, PhD;

Professor, Chair of Surgery, UCSF

Academic Appointments:

September 2010 – March 2014 University of Missouri Kansas City

Associate Professor of Surgery,

Associate Professor of Basic Sciences and

Immunology

Sept 2002 - March 2010 Baylor Regional Transplant Institute

Assistant Professor of Surgery

Director, Transplant Continuing Medical Education

3500 Gaston Avenue, Dallas, TX 75246

March 2003-March 2010 University of Texas-Southwestern


Children's Medical Center Dallas

1935 Medical District Dr., Dallas, Texas, 75235

July 2000-Sept. 2002 University of Louisville


Chief, Liver Transplantation & Hepatobiliary

Surgery

University of Louisville

Louisville, KY 40292

July 1998 - June 2000 Department of Surgery

Clinical Instructor

University of California San Francisco

Clinical Appointments:

June 2011 – March 2014 Co-Director, Henry & Marion Bloch

Liver Disease Management and Transplant Center

April 2010 – March 2014 Director, Abdominal Transplantation &

Hepatobiliary & Pancreatic Surgery

Saint Luke’s Hospital of Kansas City

September 2010 – May 2014 Saint Luke’s Hospital South

Active Staff

September 2010 – May 2014 Research Medical Center,

Kansas City, MO

Active Staff

July 1998 - June 2000 Department of Transplantation

California Pacific Medical Center

Staff

Profession Related Education:

November 7-9, 2010 American Society of Transplant Surgeons Executive Leadership

Development Program, Part I

Northwestern University Kellogg School Management

April 26-30, 2013 American Society of Transplant Surgeons Executive Leadership

Development Program Part II

Northwestern University Kellogg School of Management

July 18, 2013 Webinar Leadership Approaches for the Outsider

Joining the New Program and Leading Change

October 24, 2013 Webinar Transplant Center – Medical Center Relationships

January 16, 2014 Webinar Staff Development: How to Grow Clinical and Administrative Leaders

May 13, 2014 Webinar Performance Assessment and Quality Improvement:

Translating Data in Practice

July 27, 2014 Part III: Closing ½ day session, in conjunction with the

World Transplant Congress, San Francisco, CA

November 2012- June 2013 The Eli Broad College of Business at Michigan State

University

Executive Development Programs Strategic Leadership & Management

Professional Experience

August 2014 Healthcare & Physician Executive

Informatics & Healthcare Information Technology

Physician Practice Associate

Active Licensure

Missouri Active 05/27/2010 – 01/31/2016

Kansas Active 08/11/2010 – 06/30/2015

Texas Active 12/ 22/2002 - 05/31/2016

Inactive Licensure

Kentucky Inactive 09/24/2002 – 12/31/2006

California Inactive 06/24/1992 - 07/31/2003

Medical Boards and Certification

American Board of Surgery 2000, re-certified 2009

Health Minimally Invasive Technology Institute 2001

Open & Laparoscopic Radiofrequency Ablation

Microvascular Surgery Certification 1992

Professional Societal Memberships

American College of Surgeons (ACS)

Fellow

American Medical Association (AMA)

American Society of Clinical Oncology (ASCO)

American Society of Clinical Oncology

ASCO Health Disparities Committee

American Society of Transplantation (AST)

American Society of Transplant Surgeons (ASTS)

Infectious Disease Community of Practice

Liver & Intestine Community of Practice

American Hepato-Pancreato-Biliary Association (AHPBA)

International Hepato-Pancreato-Biliary Association (IHPBA)

American Association for the Study of Liver Diseases (AASLD)

Society of Surgical Oncology (SSO)

Kansas City Surgical Society

The Transplantation Society (TTS)

National Medical Association (NMA)

International Liver Transplantation Society (ILTS)

Texas Transplantation Society 2005-2010

Dallas County Medical Society 2003-2010

Texas Medical Association 2003-2010

Jefferson County Medical Society 2002-2003

University of California Davis Surgical Association 2001-2002

Society of Black Academic Surgeons (SSBAS) 1993-1998

Editorial Work- Ad hoc Reviewer

International Liver Transplantation Society (ILTS)

Abstract Reviewer

Journal American College of Surgeons

American Journal of Surgery

Clinical Transplantation

American Transplant Congress Abstract Reviewer

Subsection of Hepatocellular Carcinoma

Archives of Surgery

Transplantation

National Medical Association

JAMA

Transplant International

Liver Transplantation

American Journal of Transplantation

Journal of Surgical Research

Professional Committees and Boards

American Society of Transplant Surgeons 2014-Current

Reimbursement & Regulatory Compliance Committee

American Hepato-Pancreato-Biliary Association (AHPBA) 2013-Current

Program Committee 2013-Current

UMKC MMSPA Admissions Committee 2013-2014

Physicians’ Assistant Program

American Society of Clinical Oncology (ASCO) 2013-Current

Health Disparities Committee

Diversity in Oncology Committee (DOI)

Conquer Cancer Foundation

Saint Luke’s Transplant Performance Steering Committee 2012-2014

Renal Transplant Quality Committee

Liver Transplant Quality Committee

End Stage Renal Disease Committee

End Stage Liver Disease Committee

Institutional Review Board St Luke’s Hospital 2010-2014

Research Committee St Luke’s Hospital 2011-2014

Saint Luke’s Physician Specialists (SLPS) 2011-2014

Advisory Committee

Governance Board

Mid America Heart Institute 2012-2014

ASPIRE Foundation Board

American Society of Transplant Surgeons (ASTS)

Vanguard Committee 2001-2004

Membership Committee 2004-2008

Continuing Medical Education Committee 2008-2010

Communications Committee 2012-2014

Reimbursement & Regulatory Committee 2014-Current

American Society of Transplantation (AST)

Infectious Disease Community of Practice 2012-Current

Liver & Intestine Community of Practice 2012-Current

Baylor Regional Transplant Institute

Strategic Planning Finance Committee 2006–2010

At-Large Member, Baylor Research Institute 2006–2010

Institutional Review Board 2006–2010

University of Louisville/Jewish Hospital

Student Academic Grievance Committee 2001-2002

Jewish Hospital Transplant Center 2001-2002

Jewish Hospital Transplant Center Liver Committee 2000-2002

Jewish Hospital Transplant Center Renal Committee 2000-2002

End Stage Liver Disease Committee Transplant Center 2000-2002

Quality Assessment & Improvement Committee 2000-2002

Honors and Awards

The Reverend Grady Ray Brown Spirit Award

Healthcare Leadership Kansas City, MO 2012

National Institutes of Health-UCSF

Gastrointestinal Research Training Fellowship 1993-1996

Aesculapian Honor Society

Henry Ford Hospital

Summer Research Training Fellowship 1987

Wayne State University School of Medicine

Henry Halliday Scholarship 1987

Consultant Appointments

OPTN/UNOS Region 8 Regional Review Board 2011-2014

UNOS

Minority Affairs Committee 2002-2012

Chair 2009-2012

Vice Chair 2007-2009

UNOS Region 4 Representative 2007-2009

Policy Oversight Committee 2009-2012

Public Education & Outreach Initiatives 2007-2008

Novartis Advisory Board 2008-2010

Midwest Transplant Network 2010-Current

Advisory Board

Community of Practice Committee

Speakers Bureau

Roche Speakers Bureau

Astellas Speakers Bureau

Educational Responsibilities

UMKC School of Medicine MMSPA (Physician’s Assistant Program)

Admissions Committee 2013-2014

UMKC School of Medicine

Council on Evaluation 2013-2014

Faculty Development Committee 2011-2014

Faculty Recruitment and Retention

Committee 2011-2014

Resident Curriculum Committee 2011-2014

Resident evaluations

Mock Oral Examiner

Daily rounds/didactic conferences 2011-2014

UMKC GI Fellow Interviews UMKC GI Fellow Hepatology/

Transplant Rotation 2011-2014

Baylor Dallas, Transplant Institute

Fellows Trained Clinical & Teaching Responsibilities

1. Nicolas Onaca, MD 2001-2003

2. Mark Thomas, MD 2001-2003

3. Takehisa Ueno, MD PhD 2003-2005

4. Patrick Martin, MD 2004-2006

5. Toru Ikegami, MD PhD 2004-2007

6. Gomathy Narasimhan, MD 2005-2007

7. Tadahiro Uemura, MD 2004-2007

8. Dmitriy Nikitin, MD 2006-2008 * deceased 2010

9. Tariq Khan, MD 2006-2008

10. Peter Kim, MD 2008-2010

11. Koji Tomiyama, MD PhD 2008-2010

12. Baris Yildiz, MD 2009-2010

13. Keith Cavaness, DO 2009-2011

Printed Scholarship

1. Schaeffer RC Jr, Randall HB, Resk J, Carlson RW. Enzyme-linked immunosorbant assay

(ELISA) of sized-selected crotalid venom antigens by Wyeth’s polyvalent antivenom. Toxicon

26(1): 67-76, 1988.

2. Randall HB, Wachs ME, Somberg KA, Lake JR, Emond JC, Ascher NL, Roberts JP. The use of

the T-tube after orthotopic liver transplantation. Transplantation 61(2): 258-261, 1996.

3. Roberts JP, Liu T, Freise CE, Mielczarek J, Ferrell L, Randall HB, and Ascher NL. Liver

transplantation improves survival of rats bearing hepatoma-3924A. J Surg Res 65(1): 59-62,

1996.

4. Randall HB, Roberts J. Surgical reconstruction of the biliary tract following orthotopic liver

transplantation. Curr Opin Organ TX 1:82-88, 1996.

5. Omura T, Nakagawa T, Randall HB, Lin Z, Huey M, Ascher NL, Emond JC. Increased immune

responses to regenerating partial liver grafts in the rat. J Surg Res 70(1): 34-40, 1997.

6. Brown RS, Ascher NL, Lake JR, Emond JC, Bacchetti P, Randall HB, Robert JP. The impact of

surgical complications after liver transplantation on resource utilization. Arch Surg 132(10):

1098-1103, 1997.

7. Lee CM, Carter JT, Randall HB, Hirose R, Stock PG, Melzer JS, Dafoe DC, Freise CE, Alfrey

EJ. The effect of age and prolonged cold ischemia times on the national allocation of cadaveric

renal allografts. J Surg Res 91(1): 83-88, 2000.

8. Randall HB. Current treatment of hepatobiliary malignancies. J KY Med Assoc 99(9): 392-

400, 2001.

9. Marsano LS, Martin AE, Randall HB Current Nutrition in Liver Disease. Gastroenterology

18(2): 246-253, 2002.

10. Hiramoto JS, Freise CE, Randall HB, Bretan PN, Tomlanovich S, Stock PG, Hirose R.

Successful long-term outcomes using pediatric en-bloc kidneys for transplantation. Am J

Transplant 2(4): 337-342, 2002

11. Randall HB, Cao S, de Vera ME. Transplantation in elderly patients. Arch Surg 138(10): 1089-

1092, 2003.

12. Ramsay MA, Randall HB, Burton EC. Intravascular thrombosis and thromboembolism during

liver transplantation: antifibrinolytic therapy implicated? Liver Transpl 10(2): 310-314, 2004.

13. McKenna GJ, Sanchez EQ, Chinnakotla S, Randall HB, Dawson S 3rd, Jennings LW, Levy

MF, Goldstein RM, Klintmalm GB. The Baylor Regional Transplant Institute: Review of a

twenty-year experience. Clin Transpl. 2004:221-33.

14. Kusano T, Randall HB, Roberts JP, Ascher NL. The use of stents for duct-to-duct anastomosis

of biliary reconstruction in orthotopic liver transplantation. Hepatogastroenterology 52(63):

695-9, 2005.

15. Cowling T, Jennings LW, Goldstein RM, Sanchez EQ, Chinnakotla, S, Dawson III S, Randall

HB, Klintmalm GB, Levy MF. MELD Scores do not predict patient morbidity while on the

liver transplant waiting list. Transplant Proc 37(5): 2174-8, 2005.

16. Burton E, Burns DK, Opatowsky MJ, El-Feky WH, Fischbach B, Melton L, Sanchez EQ,

Randall HB, Watkins DL, Chang J, Klintmalm GK. Rabies encephalomyelitis: clinical,

neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol 62(6): 873-

82, 2005.

17. Uemura T, Sanchez EQ, Ikegami T, Watkins D, Narasimhan G, McKenna GJ, Chinnakotla S,

Dawson III, S, Randall HB, Levy MF, Goldstein RM, Klintmalm GB. Successful combined

liver and kidney transplant for COACH syndrome and 5 year follow up. Clinic Transplant 19:

717-712, 2005.

18. Sanchez, EQ, Martin AP, Ikegami T, Uemura T, Narasimhan G, Goldstein, RM, Levy MF,

Chinnakotla S, Dawson III, S, Randall HB, Saracino G, Klintmalm GB. Sirolimus conversation

after liver transplantation: improvement in measured glomerular filtration rate after 2 years.

Transplant Proc. 2005 Dec; 37 (10): 4416-23. Erratum in: Transplant Proc Jan-Feb; 38 (1):

342, 2006.

19. Ueno T, Jones G, Martin A, Ikegami T, Sanchez EQ, Chinnakotla SC, Randall HB, Levy MF,

Goldstein RM, Klintmalm GB. Clinical outcomes from hepatic artery stenting in liver

transplantation. Liver Transpl Feb 23; 12 (3): 422-427, 2006.

20. Onaca N, Levy MF, Ueno T, Martin AP, Sanchez EQ, Chinnakotla SC, Randall HB, Dawson

III, S, Goldstein RM, Davis GL, Klintmalm, GB. An outcome comparison between primary

liver transplantation and retransplantation based on the pretransplant MELD score. Transplant

International 19: 282-287, 2006.

21. Martin A, Goldstein RM, Dempster J, Netto J, Katabi N, Derrick HC, Altrabulsi B, Jennings

LW, Ueno T, Chinnakotla S, Dawson III S, Randall HB, Levy MF, Onaca N, Sanchez EQ, Orr

D, Klintmalm GB. Radiofrequency thermal ablation of hepatocellular carcinoma before liver

transplantation – a clinical and histological examination. Clin Transplant 20: 695-705, 2006.

22. Ueno T, Barri YM, Netto GJ, Martin A, Onaca N, Sanchez EQ, Chinnakotla S, Randall HB,

Dawson S, Levy MF, Goldstein RM, Klintmalm GB. Liver and kidney transplantation for

polycystic liver and kidney-renal function and outcome. Transplantation. 2006 Aug 27; 82(4):

5017.

23. Ikegami T, Sanchez EQ, Uemura T, Narasimhan G, Masannat O, Chinnakotla S, McKenna GJ,

Randall HB, Levy MF, Goldstein RM, Klintmalm GB. Liver transplantation for cystic fibrosis

in adults. Surg Today. 2008; 38(1): 26-9. Epub 2007 Dec 24.

24. Uemura T, Randall HB, Sanchez EQ, Ikegami T, Narasimhan G, McKenna GJ, Chinnakotla S,

Levy MF, Goldstein RM, Klintmalm GB. Liver retransplantation for primary nonfunction:

analysis of a 20-year single-center experience. Liver Transpl. 2007 Feb; 13(2): 227-33.

25. Ruiz R, Barri YM, Jennings LW, Chinnakotla S, Goldstein RM, Levy MF, McKenna GJ,

Randall HB, Sanchez EQ, Klintmalm GB. Hepatorenal syndrome: a proposal for kidney after

liver transplantation (KALT). Liver Transpl. 2007 Jun; 13(6): 838-43.

26. Sanchez EQ, Fischbach BV, Narasimhan G, Chinnakotla S, Nikitin D, Khan T, Randall HB,

McKenna GJ, Ruiz R, Goldstein RM, Klintmalm GB, Levy MF. Use of two expanded-criteria-

donor renal allografts in a single patient. Proc (Bayl Univ Med Cent). 2007 Jul; 20(3): 240-3.

27. Uemura T, Ikegami T, Sanchez EQ, Jennings LW, Narasimhan G, McKenna GJ, Randall HB,

Chinnakotla S, Levy MF, Goldstein RM, Klintmalm GB. Late acute rejection after liver

transplantation impacts patient survival. Clin Transplant. 2008 May-Jun; 22(3): 316-23. Epub

2008 Jan 9.

28. Boltan LE, Randall H, Barri YM. Iatrogenic Emphysematous Pyelonephritis in a Renal

Transplant Patient. Transpl Infect Dis 2008.

29. Sanchez EQ, Chinnakotla S, Khan T, Nikitin D, Vasani S, Randall HB, McKenna GJ, Ruiz R,

Onaca N, Levy MF, Goldstein RM, Docherty JC, Hurd DK, Klintmalm GB. Intraoperative

imaging of pancreas transplants allografts using Iodocyanine green with laser fluorescence.

Proc (Bayl Univ Med Cent). 2008 Jul; 21(3): 258-260.

30. Saquib R, Randall H, Chandrakantan A, Spak CW, Barri YM. West Nile Virus Encephalitis in a

Renal Transplant Recipient: The Role of Intravenous Immunoglobulin. Am J Kidney Dis. 2008

Nov; 52 (5): e19-21. Pub 2008 Aug 3.

31. Nikitin D, Jennings LW, Khan T, Sanchez EQ, Chinnakotla S, Randall HB, McKenna GJ,

Goldstein RM, Levy MF, Klintmalm GB. Twenty years of follow-up of aortohepatic conduits in

liver transplantation. Liver Transpl. 2008 Oct; 14 (10): 1486-90.

32. A Modular Analysis Framework for Blood Genomics Studies. Application to Systemic Lupus

Erythematosis. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N. Stichweh D,

Blankenship D, Li L, Munagala I, Bennett L, Allantaz F, Randall H, Johnson D, Klintmalm G,

Palucka AK, Banchereau J, Pascual V. Immunity 2008 Jul 29(1); 150-64.

33. Ikegami T, Sanchez EQ, Uemura T, Narasimhan G, Masannat O, Chinnakotla S, McKenna GJ,

Randall HB, Levy MF, Goldstein RM, Klintmalm GB. Liver transplantation for cystic fibrosis

in adults. Surg Today (The Japanese Journal of Surgery) 2008; 38(1): 26-9.

34. Uemura T, Ikegami T, Sanchez EQ, Jennings LW, Narasimhan G, McKenna GJ, Randall HB,

Chinnakotla S, Levy MF, Goldstein RM, Klintmalm GB. Late acute rejection after liver

transplantation impacts patient survival. Clin Transplant 2008 May-Jun; 22(3): 316-23.

35. Sanchez EQ, Chinnakotla S, Khan T, Nikitin D, Vasani S, Randall HB, McKenna GJ, Ruiz R,

Onaca N, Levy MF, Goldstein RM, Docherty JC, Hurd DK, Klintmalm GB. Intraoperative

imaging of pancreas transplant allografts using Iodocyanine green with laser fluorescence. Proc

(Bayl Univ Med Cent) 2008 Jul; 21(3): 258-260.

36. O’Leary J, Randall H, Onaca N, Jennings L, Klintmalm G, Davis G. Post-Liver Transplant

Survival in Hepatitis C Patients is Improving Over Time. O’Leary JG, Randall H, Onaca N,

Jennings L, Klintmalm G, Davis G. Liver Transpl. 15:360-368, 2009.

37. False aneurysm of a hepatic artery branch complicating intrahepatic islet transplantation.

Nicolas Onaca, Bashoo Naziruddin, Henry Randall, James D Meler, Edmund Sanchez, Shinichi

Hirofumi Noguchi, Andrew Jackson, Norman Dimond, Goran Klintmalm, Marlon Levy.

Transpl International 1/2/200902/2009.

38. Sanchez EQ, Melton LB, Chinnakotla S, Randall HB, McKenna GJ, Ruiz R, Onaca N, Levy

MF, Goldstein RM, Klintmalm GB. Predicting renal failure after liver transplantation from

measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation,

2010 Jan 27’89(2): 232-235.

39. Ruiz R, Jennings LW, Kim P, Tomiyama K, Chinnakotla S, Fischbach BV, Goldstein RM,

Levy MF, McKenna GJ, Melton LB, Onaca N, Randall HB, Sanchez EQ, Susskind BM,

Klintmalm GB. Indications for combined liver and kidney transplantation: propositions after a

23-yr experience. Clin Transplant. 2010 Nov, 24(6): 807-11.

40. Randall HB. Primary care physicians’ attitudes and practices regarding discussing organ

donation with their patients. J Natl. Med Assoc 2010 Jan; 102(1): 59-60.

41. W. S. Cherikh1, *

, C. J. Young2, B. F. Kramer

1, S. E. Taranto

1, H. B. Randall

3, & P. -Y. Fan

4.

Ethnic and Gender Related Differences in the Risk of End-Stage Renal Disease after Living

Kidney Donation. Am. Journal of Transplantation 2011; 11: 1650-1655.

42. Modification of the HeRO Graft Allowing Earlier Cannulation and Reduction in Catheter

Dependent Days in patients with End Stage Renal Disease: A Single Center Retrospective

Review. Deirdre Hart, Christie Gooden, L. S. Cummings, Brandt C. Wible,

John Borsa,

and

Henry Randall

43. Ethylene-Vinyl Alcohol Copolymer Endobiliary Obliteration of Hepatic Segments in a Patient

with Isolated Bile Leaks. Journal of Interventional Radiology, In press

44. Impact of Complications on Length of Stay after Liver Transplantation: A Multivariate

Analysis at a Single Center. Sanchez E, Chinnakotla S, Randall H, McKenna G, Ruiz R, Onaca

N, Levy M, Goldstein R, Klintmalm G. Transplantation, in press

45. Impact of Sirolimus on Recurrence of Hepatocellular Carcinoma after Liver Transplantation.

Chinnakotla S, Davis, Jennings L, Vasani S, Kim P, Tomiyama K, Sanchez E, Randall H,

McKenna G, Onaca N, Ruiz R, Levy M, Goldstein R, Klintmalm G. Liver Transplantation, In

press

MANUSCRIPTS (in progress)

1. West Nile Virus in Transplant Recipients

2. Microarray Analysis Profiles in Acute Cellular Rejection

3. Liver Transplantation for Acquired Immunodeficiency Syndrome

4. Liver Transplantation for Biliary Cystadenocarcinoma (Linda Lee, MD)

5. Results of a Survey on Referral to Liver Transplant: The Transplant Program’s Perspective

Book Chapters

1. Randall HB and Roberts JP. Biliary tract complications following orthotopic liver

transplantation, In: Current Opinions in Solid Organ Transplantation, 1(1): 1996.

2. Randall Henry B, McKenna Greg J, Sanchez Edmund Q, Chinnakotla Srinath, Dawson III Sherfield,

Jennings Linda W, Levy Marlon F, Goldstein Robert M and Klintmalm Goran B: "The Baylor

Regional

Transplant Institute: Review of a twenty-year experience. Clinical Transplants 2004, Chapter 19, pp.

221-234. Edited by JM Cecka and PI Terasaki. UCLA Immunogenetics Center, Los Angeles,

California, 2005

3. Randall Henry B, Klintmalm Goran B, Transplantation of the Liver, Busuttil, and Klintmalm.

Postoperative Intensive Care Unit Management: Adult Liver Transplant Recipients, 2005 2nd

edition, chapter 56.

Book Review

Randall HB. Book Review on: Transplantation of the Liver, Arch Surg 136:1208-1209, 2001.

Editorials:

Primary care physicians’ attitudes and practices regarding discussing organ donation with their

patients.

Randall HB. J Natl. Med Assoc. 2010 Jan; 102(1): 59-60

ABSTRACTS

1. Hiramoto JS, Randall HB, Freise CE, Bretan PN, Tomlanovich S, Stock PG, Hirose R.

Successful long-term outcomes in adult recipients of pediatric en block kidneys. Abstract

#1333, Am J Transplant 1(1): 473, 2001.

2. Chinnakotla S, Levy M, Jennings L, Cowling T, Onaca N, Ueno T, Raofi V, Thomas M,

Sanchez E, Dawson S, Randall H, Goldstein R, Klintmalm G. What is the quality of life

improvement (QOL) 10 years after liver transplantation (OLT)? Abstract # 352, Am J

Transplant 3(Suppl 5): 242, 2003.

3. Onaca N, Levy MF, Thomas MJ, Ueno T, Raofi V, Sanchez EQ, Chinnakotla S, Randall HB,

Dawson S, Saracino G, Jennings LW, Goldstein RM, Klintmalm GB. Liver disease etiology

and pretransplant MELD scores – relationship with mortality in the first year post transplant.

Abstract # 362, Am J Transplant 3(Suppl 5): 244, 2003.

4. Sanchez EQ, Onaca N, Thomas M, Ueno T, Raofi V, Goldstein RM, Levy MF, Chinnakotla

S, Dawson S, Randall H, Saracino G, Klintmalm GB. Rapamune conversion in long-term

liver transplant patients is effective in recovering renal function. Abstract # 675, Am J



S, Dawson S, Randall H, Saracino G, Klintmalm GB. Rapamycin use in liver transplantation:

It is well tolerated. Abstract # 862, Am J Transplant 3 (Suppl 5): 373, 2003.

6. Chinnakotla S, Goldstein R, Onaca N, Ueno T, Raofi V, Thomas M, Jennings L, Sanchez E,

Dawson S, Randall H, Levy M, Klintmalm G. Causes of mortality in 344 adult liver

transplant (OLT) recipients who survived for more than 10 years. Abstract # 886, Am J


7. Uemura T, Sanchez EQ, Martin AP, Ikegami T, Narasimhan G, McKenna GJ, Chinnakotla S,

Dawson S, Randall HB, Levy MF, Goldstein RM, Klintmalm GK. Clinical Characteristics of

Primary Non-Function in Liver Transplantation. American Transplant Congress 2005, Seattle,

WA, USA, May 23, 2005.

8. Levy MF, Jennings LW, Sanchez EQ, Chinnakotla S, Dawson S, Randall HB, McKenna GM,

Goldstein RM, Klintmalm GK. Deceased donor vessels as hepatic artery conduits. American

Transplant Congress 2005, Seattle, WA, May 21 – 25, 2005.

9. Ikegami T, Sanchez EQ, Martin AP, Narasimhan G, Chinnakotla S, Dawson S, McKenna GJ,

Randall HB, Goldstein RM, Levy MF, Klintmalm GB. American Association of Liver

Disease 2005 San Francisco, CA, USA November 2005.

10. WS Cherikh, P.Y. Fan, S Taranto, H Randall, C Young. OPTN/UNOS updated analysis on

prior kidney living donors who were subsequently placed on the waiting list. May-June 2008

American Transplant Congress

11. Chaussabel, D., C. Quinn, J. Shen, P. Patel, C. Glaser, N. Baldwin, D. Stichweh, L. Bennett,

F. Allantaz, A. Mejias, M. Ardura, E. Kaizer, L. Monnet, W. Allman, H. Randall, D. Johnson,

A. Lanier, M. Punaro, K. Wittkowski, White P., J. Fay, G. Klintmalm, O. Ramilo, A.K.

Palucka, J. Banchereau, and V. Pascual. A Modular Analysis Framework for Blood Genomics

Studies: Application to Systemic Lupus Erythematosis. Immunity, July 2008.

12. Sanchez EQ, Melton LB, Chinnakotla S, Randall HB, McKenna GJ, Ruiz R, Onaca N, Levy

MF, Goldstein RM, Klintmalm GB. Predicting renal failure after liver transplantation from

measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation

2010 Jan 27; 89(2): 232-5.

13. M. Rita Lepe, Henry B. Randall, Linda W. Jennings, Goran Klintmalm, Gary L. Davis.

Liver Transplantation Outcomes and Disparities in Minorities. Baylor University

Medical Center, Dallas, Tx, Transplant and Hepatobiliary Surgery, Saint Luke’s, Kansas City,

MO American Association for the Study of Liver Diseases

14. A Novel Procedure for Managing an Excluded Segmental Postoperative Bile Duct Leak. D. J.

Lerner1, B. C. Wible

1, P. Chesis

4, C. Gooden

2, S. Pelletier

3, Henry B. Randall American

Hepato-Pancreato-Biliary Association, March 2013

Major Invited Lectures

1. Transplantation Immunology. Lecture Series in Immunotherapeutic, Department of

Pharmacy, University of California, San Francisco, California, May 15, 1995.

2. Nursing care of the transplant patient. Pathways, Hospice and Home Care, October 30,

1996.

3. The ideal management of Graves Disease is medical! Point/Counterpoint. Grand Rounds,

University of California Davis-East Bay, November 12, 1996.

4. Genetic screening for breast cancer. Point/Counterpoint. Grand Rounds, University of

California Davis-East Bay, July 10, 1997.

5. Shunt or transplant: Management of portal hypertension, Grand Rounds, University of

California, Davis-East Bay, June 18, 1998.

6. Vascular access for dialysis. Presented at the Clinical and Basic Science Conference,

University of Louisville, July 29, 2000.

7. Liver Transplantation: An Update. Presented at Trover Clinic, Madisonville, Kentucky,

August 3, 2000.

8. Transplantation: Choosing a treatment that is right for you. National Kidney Foundation

Louisville Urban League, August 9, 2000.

9. Adult-to-Adult Live Donor and Split Liver Transplantation Update, Research Louisville –

Transplantation in the Year 2000: Where are we now? November 3, 2000.

10. “Living Liver Donation” Case Managers Program, Jewish Hospital, February 1, 2001.

11. “Transplantation” Eminance High School presentation, Henry County, February 15, 2001.

12. “Live Liver Donor Transplantation” Kentucky Chapter, American College of Surgeons,

Brown Hotel, Louisville, KY, February 16, 2001.

13. “Hepatitis C in Dialysis Patients” Dialysis Social Workers, Jewish Hospital, April 6, 2001.

14. “Tailoring immunosuppression: The use of Rapamune” Kidney Disease Program Noon

Conference, University of Louisville, August 3, 2001.

15. “Transplantation Update” Scott County Hospital, Scottsburg, IN, August 13, 2001.

16. “What’s new in liver transplantation” Family Practice Grand Rounds, University of

Louisville, September 7, 2001.

17. “The future of transplantation” Louisville Society for Radiologists, Louisville Boat Club,

September 19, 2001.

18. “Fungal infections in transplant patients” Pfizer Preceptorship with Brown Cancer Center,

Louisville Marriott East, November 2, 2001

19. “Transplantation Update” Davies County Medical Society Meeting, Owensboro, KY,

November 27, 2001.

20. “General transplantation” Shelby County West Middle School, Jewish Hospital, February

12, 2002.

21. “Transplantation Update” Grand Rounds, Department of Surgery, University of Louisville,

March 16, 2002.

22. “Infection control in immunocompromised patient” Infectious Disease Seminar, February

21, 2003.

23. “Organ donation.” The Links, Inc., Founders Day Observance at Concord Church, Dallas,

TX. November 2004.

24. “Transplantation Update” Grand Rounds, Department of Physical Medicine &

Rehabilitation. Baylor University Medical Center, Dallas, Texas. March 19th

, 2009.

25. “Transplantation Update” Grand Rounds, Saint Luke’s Hospital Transplantation Specialists.

Kansas City, MO, April 13th

, 2010.

26. “How Does the Transplant Process Work”? Grand Rounds. University of Missouri Kansas

City, Kansas City, MO. July 9th

, 2010

27. Pancreas Transplantation, Indication, techniques, and outcomes” Medicine Grand Rounds,

Saint Luke’s Hospital of Kansas City, September 10th

2010.

28. “Management of Chronic Liver Disease”. Grand Rounds Department of Medicine, February

4th

, 2011.

29. “Management of Hepatocellular Carcinoma” Grand Rounds. CMSA, Kansas City, MO May

11th

, 2011

30. “Ethical Issues in Transplantation Part II. Swartz Rounds, Bioethical Rounds.

Saint Luke’s Hospital of Kansas City, May 5th

, 2011

31. “Clinical Transplantation & Transplant Immunology”. UMKC Medical Students (Second

Year) & Graduate Student Lecture Series in Immunology. August 2011

32. “Liver Transplants and Hepatobiliary Disease & Malignancies” MSRT Radiology

Conference sponsored by St. Luke’s Northland Hospital Saturday, September 17, 2011.

33. “Minority Affairs Committee Update”, Association for Multicultural Affairs in

Transplantation (AMAT) Annual Meeting, September 22, 2011 Tampa, Florida

34. Liver Transplantation for Hepatocellular Carcinoma. Missouri Society of the American

College of Osteopathic Family Physicians, January 2012 Winter Scientific Seminar.

35. Perfusion’s Role in Liver Transplantation. The Missouri Perfusion Society, 17th

Annual

Scientific Meeting, Kansas City, MO, June 8, 2012.

36. A Primer on Pancreatic Cancer. Lunch and Learn for Cancer Support Volunteers of the R.A.

Bloch Cancer Foundation. Kansas City, MO, October 18, 2012

PRESENTATIONS

1. Randall HB, Henderson VJ, Organ CH. The negative trauma celiotomy.

National Medical Association-Surgical Section, Surgical Resident Competition.

Indianapolis, Indiana, August 8, 1991.

2. Randall HB, Nacamuli R, Liu T, Ascher NL, Robert JP. Mycophenolate mofetil inhibits

arterial

intimal hyperplasia caused by mechanical injury in the rat common carotid artery.

Society of University Surgeons, Denver, Colorado, February 10, 1994.

3. Randall HB, Nacamuli R, Lin Z, Liu T, Ascher NL, Robert JP. Production of IL-13 in

long-term survivors of an allogeneic liver transplant. National Medical Association-

Surgical Section Resident Research Competition. Orlando, Florida, July 26, 1994.

4. Randall HB, Roberts JP. Cost of complications following orthotopic liver transplantation.

Grand Rounds, Department of Surgery, University of California, San Francisco, September

18, 1994.

5. Randall HB, Nacamuli R, Huey M, Liu T, Ascher NL, Roberts JP.

Expression of cytokine mRNA in a tolerized rat liver transplant model: Effect of

cyclosporine.

American Association for the Study of Liver Diseases, Chicago, Illinois, November 13,

1994.

6. Randall HB, Wachs ME, Emond JC, Lake JR, Ascher NL, Robert JP.

Use of the T-tube in the biliary tract following orthotopic liver transplantation.

American Society of Transplant Surgeons, Chicago, Illinois, May 1995.

7. Randall HB, Tsao G, Justice J, Huey M, Ascher N, Roberts J.

Suppression of proinflammatory cytokines by a novel Th-2 cytokine.

Society of Black Academic Surgeons, Denver, Colorado, April 2, 1996.

8. Omura T, Nakagawa T, Randall HB, Lin Z, Huey M, Ascher NL, Emond JC.

Regenerating liver allografts are associated with enhanced host immune responses.

Poster presentation at the American Society of Transplant Surgeons, Dallas, TX, May 28,

1996.

9. Koppie TM, Randall HB, Hirose R, Freise CE, Melzer JS. Polyoma virus infection in the

renal allograft: A single center experience. American Society of Transplant Surgeons,

Chicago, Illinois, May 1999.

10. Lee CM, Carter JT, Randall HB, Hirose R, Stock PG, Melzer JM, Dafoe DC, Freise CE,

Alfrey EJ. Poorer outcome in older donor kidneys with prolonged cold ischemia times

(CIT=s): National Allocation of Older Cadaveric Renal Allografts. Presented at the

Association for Academic Surgery meeting as an oral presentation, November 1999.

11. Onaca N, Levy MF, Thomas MJ, Ueno T, Raofi V, Sanchez EQ, Chinnakotla S, Randall,

HB, Dawson S, Saracino G, Jennings LW, Goldstein RM, and Klintmalm GB. Liver disease

etiology and pretransplant MELD scores - relationship with mortality in the first year post

transplant. American Transplant Congress, Washington, DC, May 30-June 4, 2003 (poster

presentation)


S, Dawson S, Randall HB, Saracino G, Klintmalm GB. Rapamune conversion in long-term

liver transplant patients is effective in recovering renal function. American Transplant

Congress, Washington, DC, May 30-June 4, 2003 (oral presentation)


S, Dawson S, Randall HB, Saracino G, Klintmalm GB. Rapamycin use in liver

transplantation: it is well tolerated. American Transplant Congress, Washington, DC, May

30-June 4, 2003 (poster presentation)

14. Benjamin D Brielmaier, Srinath Chinnakotla, Mai T Franklin, Tadahiro Uemura, Gomathy

Narasimhan, Ousama Masannat, Louis M Sloan, William L Sutker, Greg J McKenna, Henry

B Randall, Edmund Q Sanchez, Marlon F Levy, Robert M Goldstein, Goran B Klintmalm.

Invasive fungal infections following liver transplantation: Analysis of 2656 patients

transplanted at a single center. World Transplant Congress 2006, Boston, MA, July 22-27,

2006. (Oral presentation)

15. Benjamin D Brielmaier, Srinath Chinnakotla, Mai T Franklin, Tadahiro Uemura, Gomathy

Narasimhan, Ousama Masannat, Louis M Sloan, William L Sutker, Greg J McKenna, Henry

B Randall, Edmund Q Sanchez, Marlon F Levy, Robert M Goldstein, Goran B Klintmalm.

Fungal infection prophylaxis in liver transplant recipients: The role of low-dose

Amphotericin B. World Transplant Congress 2006, Boston, MA, July 22-27, 2006. (Oral

presentation)

16. Srinath Chinnakotla, Douglas M Smith, Rana Domiati-Saad, Edward D Agura, David L

Watkins, George J Netto, Tadahiro Uemura, Gomathy Narasimhan, Ousama Masannat, Greg

J McKenna, Henry B Randall, Edmund Q Sanchez, Marlon F Levy, Robert M Goldstein,

Goran B Klintmalm. Acute graft versus host disease after liver transplantation: role

withdrawal of immunosuppression in therapeutic management. World Transplant Congress

2006, Boston, MA, July 22-27, 2006. (Oral presentation)

17. Srinath Chinnakotla, Robert M Goldstein, Douglas Orr, Gary L Davis, Gomathy

Narasimhan, Tadahiro Uemura, Ousama Masannat, Linda W Jennings, Greg J McKenna,

Henry B Randall, Edmund Q Sanchez, Marlon F Levy, Goran B Klintmalm. Pattern of

recurrence of hepatocellular carcinoma after liver transplantation. World Transplant

Congress 2006, Boston, MA, July 22-27, 2006. (Oral presentation)

18. Srinath Chinnakotla, Mohammad Ashfaq, Gary L Davis, Gomathy Narasimhan, Tadahiro

Uemura, Ousama Masannat, Edmund Q Sanchez, Henry B Randall, Greg J McKenna, Robert

M Goldstein, Marlon F Levy, Michael Ramsay, Goran B Klintmalm. Liver transplantation in

patients with severe Porto pulmonary hypertension. World Transplant Congress 2006,

Boston, MA, July 22-27, 2006. (Oral presentation)

19. Robert M. Goldstein, Brian D. Berger, Chase Derrick, Jane A. Dempster, Cindy Smith,

Janice Delp, Edmund Q. Sanchez, Srinath Chinnakotla, Henry B. Randall, Gregory J.

McKenna, Marlon F. Levy, Goran B. Klintmalm. Radiosurgery as a Bridge to Liver

Transplantation. American Transplant Congress 2007, San Francisco, CA, May 5-9, 2007.

(Poster presentation)

20. Richard Ruiz, Yousri M. Barri, Jennings W. Linda, Srinath Chinnakotla, Robert M.

Goldstein, Marlon F. Levy, Greg J. McKenna, Nicholas Onaca, Henry B. Randall, Edmund

Q. Sanchez, Goran B. Klintmalm. Hepatorenal Syndrome: A Proposal for Kidney after Liver

Transplantation (KALT). American Transplant Congress 2007, San Francisco, CA, May 5-9,

2007. (Poster presentation)

21. Henry B. Randall, G. J. McKenna, L. B. Melton, L. Sloan, S. Chinnakotla, E. Q. Sanchez, R.

Ruiz, N. Onaca, M. F. Levy, R. M. Goldstein, G. B. Klintmalm. Post transplant Acquired

West Nile Virus Infection: A Single Center Report of Nine Cases. American Transplant

Congress 2007, San Francisco, CA, May 5-9, 2007. (Poster presentation)

22. Greg J. McKenna, Edmund Q. Sanchez, Srinath Chinnakotla, Henry B. Randall, Richard

Ruiz, Nicholas Onaca, Dmitriy Nikitin, Tariq Khan, Marlon F. Levy, Robert M. Goldstein,

Goran B. Klintmalm. Liver Transplant Secondary Non-Function: Defining a Delayed

Cholestatic Graft Failure. American Transplant Congress 2007, San Francisco, CA, May 5-9,

2007. (Poster presentation)

23. Edmund Q. Sanchez, Dmitriy Nikitin, Tariq Khan, Srinath Chinnakotla, Robert M.

Goldstein, Marlon F. Levy, Henry B. Randall, Greg J. McKenna, Richard Ruiz, Nicholas

Onaca, Goran B. Klintmalm. Rabbit Anti-Thymocyte Globulin (RATG) Is a Safe and

Effective Agent for Steroid-Resistant Rejection (SRR) in Liver Transplantation. American

Transplant Congress 2007, San Francisco, CA, May 5-9, 2007. (Poster presentation)

24. Greg J. McKenna, Edmund Q. Sanchez, Srinath Chinnakotla, Henry B. Randall, Richard

Ruiz, Nicholas Onaca, Dmitri Nikitin, Tariq Khan, Robert M. Goldstein, Marlon F. Levy,

Goran B. Klintmalm. The Impact of a Change to a Steroid-Free Immunosuppression

Regimen on Rejection and CMV Incidence in Liver Transplant Patients. American

Transplant Congress 2007, San Francisco, CA, May 5-9, 2007. (Poster presentation)

25. Dmitriy Nikitin, Tariq Khan, Edmund Q. Sanchez, Srinath Chinnakotla, Henry B. Randall,

Greg J. McKenna, Richard Ruiz, Nicholas Onaca, Robert M. Goldstein, Marlon F. Levy,

Goran B. Klintmalm. Surgical Assessment of Donor Liver Steatosis. American Transplant

Congress 2007, San Francisco, CA, May 5-9, 2007. (Poster presentation)

26. Nicholas Onaca, Srinath Chinnakotla, Dmitriy Nikitin, Tariq Khan, Edmund Q. Sanchez,

Linda W. Jennings, Greg McKenna, Richard Ruiz, Henry B. Randall, Robert M. Goldstein,

Marlon F. Levy, Goran B. Klintmalm. Hepatocellular Carcinoma in Patients with Chronic

27. Srinath Chinnakotla, M. J. Stone, D. Nikitin, T. Khan, E. Q. Sanchez, R. M. Goldstein, M. F.

Levy, H. B. Randall, G. J. McKenna, R. Ruiz, N. Onaca, G. B. Klintmalm. The Long-Term

Results of Liver Transplantation (LT) for Budd-Chiari Syndrome without Use of

Anticoagulation. American Transplant Congress 2007, San Francisco, CA, May 5-9, 2007.

(Oral presentation)

28. Srinath Chinnakotla, L. W. Jennings, D. Nikitin, T. Khan, E. Q. Sanchez, R. M. Goldstein,

M. F. Levy, H. B. Randall, G. J. McKenna, R. Ruiz, N. Onaca, G. B. Klintmalm. Impact of

Sirolimus, Cyclosporine-Based Immunosuppression on Tumor Recurrence and Survival in

Patients Transplanted for Hepatocellular Carcinoma (HCC). American Transplant Congress

2007, San Francisco, CA, May 5-9, 2007. (Oral presentation)

29. Greg J. McKenna, Richard Ruiz, Edmund Q. Sanchez, Srinath Chinnakotla, Henry B.

Randall, Nicholas Onaca, Tariq Khan, Dmitriy Nikitin, Robert M. Goldstein, Marlon F.

Levy, Goran B. Klintmalm. Migration to Steroid-free Immunosuppression: The impact on

the incidence of rejection and CMV infection. The International Liver Transplantation

Society, 13th Annual International Congress, Rio de Janeiro, Brazil, June 20-23, 2007.

(Poster presentation)

30. Nicholas Onaca, Edmund Q. Sanchez, Tariq Khan, Dmitriy Nikitin, Srinath Chinnakotla,

Linda W. Jennings, Richard Ruiz, Greg J. McKenna, Henry B. Randall, Robert M.

Goldstein, Marlon F. Levy, Goran B. Klintmalm. Transplantation for Hepatocellular

Carcinoma in Patients with Chronic Hepatitis C - Is Survival Worse Than with Hepatitis C

Alone? The International Liver Transplantation Society, 13th Annual International Congress,

Rio de Janeiro, Brazil, June 20-23, 2007. (Oral presentation)

31. Sanchez EQ, Khan T, Nikitin D, Vasani S, Chinnakotla S, Randall H, McKenna G, Ruiz R,

Onaca N, Levy MF, Goldstein RM and Klintmalm GB. The effect of immunosuppression on

long-term FGR, a comparison of tacrolimus, cyclosporine, and sirolimus. American

Transplant Congress, Toronto, Canada. May 31 – June 4, 2008 (poster presentation)

32. Sanchez EQ, Khan T, Nikitin D, Vasani S, Chinnakotla S, Randall H, McKenna G, Ruiz R,

Onaca N, Levy MF, Goldstein RM and Klintmalm GB. Intraoperative fluorescence imaging

(IFI) in renal transplantation (RT) to demonstrate vascular patency and allograft perfusion.

American Transplant Congress, Toronto, Canada. May 31 – June 4, 2008 (poster

presentation)

33. McKenna GJ, Sanchez EQ, Nikitin D, Vasani S, Khan T, Chinnakotla S, Randall HB, Ruiz

R, Onaca N, Levy MF, Goldstein RM and Klintmalm GB. Outcomes using sirolimus as

initial immunosuppression for liver transplants: A 10-year experience. American Transplant

Congress, Toronto, Canada. May 31 – June 4, 2008 (poster presentation)

34. McKenna GJ, Sanchez EQ, Khan T, Nikitin D, Vasani S, Chinnakotla S, Randall HB, Ruiz

R, Onaca N, Levy MF, Goldstein RM and Klintmalm GB. Sirolimus as initial

immunosuppression in liver transplants: Changes over a 10-year period. American



R, Onaca N, Levy MF, Goldstein RM and Klintmalm GB. Protection from cytomegalovirus

infection using sirolimus as initial immunosuppression in liver transplants. American



R, Onaca N, Levy MF, Goldstein RM and Klintmalm GB. Sirolimus and hepatic artery

complications: Reassessing the black box warning? American Transplant Congress, Toronto,

Canada. May 31 – June 4, 2008 (oral presentation)

37. Sanchez EQ, Chinnakotla S, Randall HB, McKenna GJ, Ruiz R, Onaca N and Klintmalm

GB. Renal failure after liver transplant (LT) is dependent on month 3 GFR, a long-term

review of up to 15-year Glofil data. American Transplant Congress, Toronto, Canada. May

31 – June 4, 2008 (oral presentation)

38. Sugam Vasani, Tariq Khan, Dmitriy Nikitin, Edmund Q. Sanchez, Srinath Chinnakotla,

Henry B. Randall, Greg J. McKenna, Richard Ruiz, Nicholas Onaca, Marlon F. Levy, Robert

M. Goldstein, Goran B. Klintmalm. Utility of long-term protocol liver biopsy without

biochemical graft dysfunction in orthotopic liver transplantation. 14th Annual Congress of

the International Liver Transplantation Society, Paris, France, July 9-12, 2008. (Oral

presentation)

39. R. Ruiz, H. Randall, R. Goldstein, G. Klintmalm, M. Levy, G. McKenna, N. Onaca, L.

Jennings, E. Sanchez, S. Chinnakotla. Combined liver-kidney transplantation: MELD era

trends. 22nd International Congress of the Transplantation Society, Sydney, Australia,

August 10-14, 2008. (Poster presentation)

40. Richard Ruiz, Massimo Asolati, Linda W. Jennings, Srinath Chinnakotla, Robert M.

Goldstein, Marlon F. Levy. Greg J. McKenna, Nicolas Onaca, Henry B. Randall, Goran Bo

Klintmalm. Liver Transplantation in Septuagenarians: Do We Draw a Line? 10th American

Transplant Congress, San Diego, CA. May 1-5, 2010.

41. D. J. Lerner1, B. C. Wible

1, P. Chesis

4, C. Gooden

2, S. Pelletier

3, H. B. Randall

2;

1University

Of Missouri - Kansas City Diagnostic And Interventional Radiology, Kansas City,

MISSOURI; 2St. Luke’s Hospital, Kansas City, MISSOURI;

3University Of Michigan Health

Systems, Ann Arbor, MICHIGAN; 4SSM St. Joseph Health Center, St. Charles, MO. A

NOVEL PROCEDURE FOR MANAGING EXCLUDED SEGMENTAL

POSTOPERATIVE BILE DUCT LEAK. American Hepato-Pancreato-Biliary Association,

Miami Beach, FL, February, 2013.

42. Hepatitis C: Implications for Survival after Liver Transplantation. American Transplant

Congress 2007, San Francisco, CA, May 5-9, 2007. (Oral presentation)

43. Liver Transplantation for Unresectable Hepatoblastoma in Children. Chinnakotla S, Mittal

N, Stegner M, Blair A, Cutright L, Sanchez E, Ruiz R, McKenna G, Randall H, Klintmalm.

American Transplant Congress 2009, Boston MA, USA.

44. Prior Living Donors Who Subsequently Needed Chronic Maintenance Dialysis. Cherikh W,

Maghirang J, Carroll C, Randall H, Young C. UNOS, University of Massachusetts, Baylor

University Medical Center, University of Alabama. American Transplant Congress, 2009,

Boston MA, USA.

45. Converting Existing Patients to a Sirolimus Based Calcineurin Inhibitor Free

Immunosuppression in Liver Transplant: It Can Be Done Safely. McKenna G, Sanchez E,

Chinnakotla S, Randall H, Onaca N, Ruiz R, Levy M, Goldstein R, Klintmalm G. American

Transplant Congress, 2009, Boston, MA, USA.

46. Richard Ruiz, Peter Kim, Linda Jennings, Srinath Chinnakotla, Edmund Q. Sanchez,

Nicholas Onaca, Greg McKenna, Henry Randall, Marlon Levy, Robert Goldstein, Goran B.

Klintmalm. The Impact of Immunosuppression on Incisional Hernias after Liver

Transplantation. 10th American Transplant Congress, San Diego, CA. May 1-5, 2010

47. Greg J. McKenna, James Trotter, Erik Klintmalm, Srinath Chinnakotla, Henry Randall,

Nicholas Onaca, Richard Ruiz, Marlon F. Levy, Robert M. Goldstein, Goran B. Klintmalm.

Limiting Hepatitis C Virus (HCV) Progression in Liver Transplant Recipients Using

Sirolimus Based Immunosuppression. 10th American Transplant Congress, San Diego, CA.

May 1-5, 2010.

48. Srinath Chinnakotla, Jill Rockwell, Lisa Cutright, Richard Ruiz, Gregory McKenna, Marlon

F. Levy, Henry B. Randall, Peter B. Kim, Baris Yildiz, Keith Cavaness, Naveen Mittal,

Goran B. Klintmalm. Long-Term Results of ABO Incompatible Liver Transplantation

(ABOI) in Children. 10th American Transplant Congress, San Diego, CA. May 1-5, 2010.

49. S. Chinnakotla, G.L. Davis, J.F. Trotter, H. Randall, G.J. McKenna, R. Ruiz, N. Onaca, M.

Asolati, P. Kim, K. Tomiyama, K. Cavaness, B. Yildiz, L. Jennings, M.F. Levy, R.

Goldstein, G. Klintmalm. Factors Affecting Recurrence of Hepatitis C after Liver

Transplantation—Correlation with Histology on Protocol Liver Biopsies. XXIII International

Congress of The Transplantation Society, Vancouver, Canada, August 15-19, 2010

50. R. Ruiz, K. Tomiyama, S. Chinnakotla, R. Goldstein, M.F. Levy, G.J. McKenna, N. Onaca,

H. Randall, B. Susskind, L. Jennings, G.W. Tillery, G. Klintmalm. The Positive Crossmatch

in Liver Transplantation: A Risk Factor for Preservation Injury? XXIII International

Congress of The Transplantation Society, Vancouver, Canada, August 15-19, 2010

51. Results of National Survey of Referral to Kidney Transplant: The Transplant Program’s

Perspectives. Wida Cherikh, Silas Norman, Pang-Yen Fan, Deanna Parker, Henry Randall.

May 3rd, 2011. Session: Disparities in Access to Transplantation. American Transplant

Congress

52. M. Rita Lepe, Henry B. Randall, Linda W. Jennings, Goran Klintmalm, Gary L. Davis. Liver

Transplantation Outcomes and Disparities in Minorities. Baylor University Medical Center,

Dallas, TX, Transplant and Hepatobiliary Surgery, Saint Luke’s, Kansas City, MO American

Association for the Study of Liver Diseases. October 29th

– November 2nd

2010, Boston,

MA.

Funding

Henry & Marion Bloch Endowment $ 1,500,000.00 (2011 – 2014)

Research

Principal Investigator

Bristol Myer Squibb

Belatacept in Renal Transplantation

Co-Investigator

Induction of Donor Specific Tolerance in Recipients of Kidney Allografts by Donor Bone

Marrow

Cell Infusion Clinical Trial


Wyeth Protocol 0468HI-101164 (IRB 002-216)

An Open-Label, Concentration-Controlled, Randomized, 12-Month Study of Prograf +

Rapamune + Corticosteroids Compared to Cyclosporine Microemulsion Capsules, USP

(Modified) + Rapamune + Corticosteroids in High Risk Renal Allograft Recipients.

Co-Investigator

FDA-approved study with Novartis (IRB 003-016)

Protocol FTY720 0125 $231,543.24

Evaluate the Efficacy & Safety of FTY720 Combined with Reduced-Dose or Full–Dose

Neoral & Corticosteroids vs. MMF/CellCept Combined with Full-Dose Neoral &

Corticosteroids, in de novo Adult Renal Transplant Recipients.

Co-Investigator

Clinical Trial, Protocol # 02-01-L (IRB 002-039)

An Open-Label, Randomized, Prospective Multicenter Study to Compare the Efficacy and

Safety among Three Treatment Regimens in Patients Receiving a Liver Transplant for End-

Stage Liver Disease Caused by Chronic Hepatitis C Infection.

Co-Investigator

Fujisawa Protocol 02-1-138 (IRB 002-233)

A Phase II, Open-Label, Multi-Center Study to Access the Pharmacokinetics, Long-Term

Safety and Tolerability of Tacrolimus in Stable Liver Transplant Patients Converted from a

Prograf Based Immunosuppression Regimen to a Modified Release (MR) Tacrolimus Based

Immunosuppression Regimen.

Co-Investigator

Novartis Myfortic 002-010

One Year Multicenter Open-Label, Prospective, Randomized Study to compare the effect of

two Neoral C-2h maintenance targets, beyond two months post Transplant on renal function

in the context of an immunosuppressive regimen Consisting of Myfortic Simulect and

steroids.

Co-Investigator

Baylor Zenapax Pharmacokinetic Substudy159 002-039

An Open-Label randomized prospective multicenter study to compare the Efficacy and safety

among three treatment regimens in patients received a Liver transplant for end-stage liver

disease caused by chronic Hepatitis C Infection.

Co-Investigator

Baylor Thymo 002-109

Tolerance Induction in Liver Transplant Recipients through a Preconditioning Regimen

Including Thymoglobulin and Tacrolimus Monotherapy with Gene Chip Monitoring

Co-Investigator

Thymo 002-157

Pilot Trial of Operational Tolerance Induction in Liver Transplant Recipients through a

Preconditioning

Regiment Including Thymoglobulin and Tacrolimus Monotherapy with Gene Chip

Monitoring

Co-Investigator

Fujisawa 02-0-152

A Phase II, Open-Label Multi=Center Study to Assess the Pharmacokinetics Long-Term

Safety and Tolerability of Tacrolimus in Stable Liver Transplant Patients Converted From a

Prograf® Based Immunosuppression Regimen to a Modified Release (MR) Tacrolimus Based

Immunosuppression

Co-Investigator

Baylor Islet Cell 003-040

Pancreatic Islet Cell Transplantation—Validation of Remote Site Islet Cell Processing Islet

Cell Culture and two layer Preservation Method

Co-Investigator

University of Penn MPA-003-014

Mycophenolic Acid Pharmacokinetics Following Liver Transplantation Sub study to Protocol

ZEN159: A Double Blind Randomized Study to Assess the Efficacy and Safety of Zenapax in

Combination with CellCept, Tacrolimus and Corticosteroids in Patients Undergoing Liver

Transplantation.

Co-Investigator

Baylor Chimerism 003-127

Donor T-Lymphocyte Chimerism in Liver Transplant Patients (The Persistence of Donor

Blood Cells in Patients who have received a Liver Transplant).

Co-Investigator

Idun Pharmaceuticals Idun 003-142

Safety Tolerability and Efficacy Study of a Caspase Inhibitor IDN-6556 in Patients

Undergoing Orthotopic Liver Transplantation (OLT).

Co-Investigator

Odyssey CUES 003-207

A Multicenter Prospective Randomized Comparison of the Effectiveness of Custodiol HTK

Solution with Viaspan UW Solution in the In-Situ Perfusion Storage and Transplantation of

Cadaveric-Donor Kidneys and Livers

Co-Investigator

Genzyme THYMO1 004-028

A Randomized Controlled Multicenter Study of Thymoglobulin Induction Therapy with a

Calcineurin Inhibitor Sparing Regimen in Liver Transplant Patients

Co-Investigator

Immune Tolerance ITN024S 004-108.

A Phase II Multicenter Trail to Assess the Safety and Efficacy of Campath-1 H and

Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation.

Co-Investigator

Idun Pharmaceuticals Treatment 004-124

Treatment Protocol for Exceptional Use of A Caspase Inhibitor in Patients Undergoing

Orthotopic Liver Transplantation


ViroPharma Incorporated: 1263-301

A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Prophylactic Use of

Maribavir versus Oral Ganciclovir for the Prevention of Cytomegalovirus in Recipients of

Orthotopic Liver Transplants


Wyeth – Rapa 4500 Study

Co-Investigator

Novadaq 006-216

SPY-Imaging Device

Co-Investigator

Genzyme 002-075

Thymoglobulin versus OKT3 for Treatment of Steroid Resistant Acute Cellular Rejection in


Co-Investigator

Roche 004-062

Open-Label, Prospective, Randomized, Controlled Multicenter Study Assessing Fixed Dose

vs. Concentration Controlled CellCept Regimens for Patients Following a Single Organ Renal

Transplantation in Combination

with Full Dose and Reduced Dose Calcineurin Inhibitors.

Co-Investigator

Pfizer 007-117

A phase 2 Randomized Multicenter, Active Comparator-Controlled Trial to Evaluate the

Safety and Co administration of CP-690-550 and Mycophenolate Mofetil/Mycophenolate

Sodium in De Novo Kidney Allograft Recipients.

Co-Investigator

Astellas 006-106

A phase IIIb Randomized Open-Label, Comparative Multicenter Study to Assess the Safety

and Efficacy of Prograf vs. Modified Release Tacrolimus (MR) with CellCept and Steroid

Withdrawal in De Novo Liver Transplant Recipients.

Co-Investigator

Isotechnika 005-177

A Phase IIB, Randomized, Multicenter, Open-Label Concentration

Co-Investigator

Pfizer 007-117

A Phase 2 Randomized Multicenter, Active Comparator-Controlled Trial to Evaluate the

Safety and Efficacy of Co administration of CP-690-550 and Mycophenolate

Mofetil/Mycophenolate Sodium in De Novo Kidney Allograft Recipients

Co-Investigator

Astellas 006-106

A Phase IIIb Randomized Open-Label, Comparative Multi-Center Study to Assess the Safety

and Efficacy of Prograf vs. Modified Release Tacrolimus (MR) with CellCept and Steroid

Withdrawal in de novo Liver Transplant Recipients

Co-Investigator 005-177

Phase IIB, Randomized, Multicenter, Open-Label Concentration-Controlled, Safety Study of

ISA247 and Tacrolimus (Prograf) In De Novo Renal Transplant Patients

Co-Investigator

Novartis 005-159

Randomized Evaluation of Fibrosis Due to Hepatitis C after De Novo Liver Transplant - A

Multicenter Randomized, Open Label Study to Compare the Development of Liver Fibrosis at

12 Months after Transplantation for Hepatitis C Cirrhosis in Patients Receiving Either Neoral

or Tacrolimus

Co-Investigator

Pfizer 005-158)

A Multicenter Phase 2, Open Label Controlled, Extension Study for Stage 1 Subjects of Study

A3921009 to Evaluate the Long Term Safety and Efficacy of CP-690, 550 versus Tacrolimus

when Co-Administered with Mycophenolate Mofetil in Renal Allograft Recipients

Co-Investigator

Novartis 005-157

Y's Therapeutics A Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase

I/II Intravenous, Single Dose, Dose Escalating Study of the Safety, Pharmacokinetics, and

Efficacy of YSPSL for Prevention of Delayed Graft Function in Patients Undergoing

Cadaveric Kidney Transplantation

Co-Investigator

Roche 005-112

A Prospective Open Label, Multicenter Randomized Trial of the Efficacy and Safety of a

Long Term Calcineurin Inhibitor Free Maintenance Regimen with Mycophenolate Mofetil

and Sirolimus in Recipients of an Orthotopic Liver Transplant

Co-Investigator

Pfizer 005-005

A 6-Month, Phase 2, Multicenter, Randomized, Open Label, Comparative Study of 2 Dose

Levels of CP-690, & CP-550 Administered Concomitantly With IL-2 Receptor Antagonist

Induction Therapy, Mycophenolate Mofetil and Corticosteroids Versus A Tacrolimus Based

Immunosuppressive Regimen For The Prevention Of Allograft Rejection in De Novo Renal

Allograft Recipients

Co-Investigator

Novartis 004-045

A Facilitated Access Program to Provide Everolimus (RAD) for Maintenance for Patients

Completing Therapy in RAD Trials in Solid Organ Transplantation

Co-Investigator

Genzyme 004-028

A Randomized, Controlled, Multicenter Study of Thymoglobulin Induction Therapy with a

Calcineurin-Inhibitor Sparing Regimen in Liver Transplant Patients

Co-Investigator

Odyssey 003-207

A Multicenter, Prospective, Randomized Comparison of the Effectiveness of Custodiol

HTK Solution with Viaspan UW Solution in the In-Situ Perfusion, Storage, and

Transplantation of Cadaveric-Donor Kidneys and Livers

Co-Investigator

Heidelberg 003-186

Heidelberg Registry - Collaborative Transplant Study

Co-Investigator

Astellas 002-233

A Phase II, Open-Label, Multi-Center Study to Assess the Pharmacokinetics, Long-Term

Safety and Tolerability of Tacrolimus in Stable Liver Transplant Patients Converted From a

Prograf® Based Immunosuppression Regimen to a Modified Release (MR) Tacrolimus Based

Immunosuppression

Principle Investigator

Baylor 002-039

Baylor Department Immunomonitoring of Transplant Patients

An Open-label randomized, prospective multicenter study to compare the efficacy and safety

among three treatments regimens in patients receiving a liver transplant for end-stage liver

disease caused by chronic hepatitis C infection

Co-Investigator

Novartis 005-149

A 24-Month Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy, and

Safety Comparing Concentration-Controlled Certican in Two Doses (1.5 and 3.0 mg/day

starting doses) with Reduced Neoral versus 1.44 g Myfortic with Standard Dose Neoral in De

Novo Renal Transplant Recipients

Co-Investigator

Baylor 003-040

Pancreatic Islet Cell Transplantation – Validation of Remote Site Islet Cell Processing, Islet

Cell Culture, and Two-Layer Preservation Method

Co-Investigator

Novadaq 006-216

SPY Imaging Device

Co-Investigator

Genzyme 002-075

Thymoglobulin versus OKT3 for Treatment of Steroid Resistant Acute Cellular Rejection in


Co-Investigator

Roche 004-062

Label, Prospective, Randomized Controlled Multicenter Study Assessing Fixed Dose vs.

Concentration Controlled CellCept Regimens for Patients Following a Single Organ Renal

Transplantation in Combination with Full Dose and Reduced Dose Calcineurin Inhibitors

Co-Investigator

Roche 003-109

An Open Label Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Early

Calcineurin Inhibitor

Withdrawal in Recipients of Primary Renal Allografts Maintained Long-Term on

Mycophenolate Mofetil: MMF and Sirolimus

Co-Investigator

Fujisawa 003-076

A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety

and Efficacy of Prograf (tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and

Neoral (cyclosporine)/MMF in de novo Kidney Transplant Recipients

Co-Investigator

Bristol Myers Squibb 005-178

Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression

(BENEFIT)

Co-Investigator

Novartis 005-150

A 24-Month Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy, and

Safety Comparing Concentration-Controlled Certican in Two Doses (1.5 and 3.0 mg/day

starting doses) with Reduced Neoral versus 1.44 g Myfortic with Standard Dose Neoral in De

Novo Renal Transplant Recipients

Co-Investigator


Belatacept Evaluation of Nephroprotection and Efficacy as First Line Immunosuppression

Trial - Extended Criteria Donors

Co-Investigator


Phase II/III, Open-Label, Randomized, Controlled, Multiple-Dose Study of Efficacy and

Safety of BMS-224818 as Part of a Quadruple Drug Regimen in First Renal Transplant

Recipients International HLA Chronic Rejection Registry 004-205 Immunogenetics WS

Co-Investigator

Immune Tolerance / NIH 004-108

A Phase II Multicenter Trial to Assess the Safety and Efficacy of Campath-1H and

Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation

Co-Investigator

Mayo, NIH 003-074

Liver Transplantation: Models for Patient Management and Resource Allocation CKD-EPI,

NIDDK, and NIH Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)

Co-Investigator

NIH, NIDDK 001-033

A Multi-Center Group to Study Acute Liver Failure

Co-Investigator

NIH, UTSW

A Multicenter Study of the Safety and Efficacy of N-acetylcysteine in the Treatment of

Acute Liver Failure Not Caused by Acetaminophen


Wyeth 0468E8-4500-WW

Planned Transition to Sirolimus-based Therapy versus Continued Tacrolimus-based

Therapy in Renal Allograft Recipients Phase 3B/4

cardinal glennon children’s medical center -...

Documents